1. Home
  2. NVEC vs DCTH Comparison

NVEC vs DCTH Comparison

Compare NVEC & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NVE Corporation

NVEC

NVE Corporation

HOLD

Current Price

$114.36

Market Cap

398.4M

Sector

Technology

ML Signal

HOLD

Logo Delcath Systems Inc.

DCTH

Delcath Systems Inc.

HOLD

Current Price

$11.79

Market Cap

372.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVEC
DCTH
Founded
1989
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
398.4M
372.5M
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
NVEC
DCTH
Price
$114.36
$11.79
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$22.00
AVG Volume (30 Days)
182.8K
514.7K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
5.13%
N/A
EPS Growth
0.96
107.53
EPS
3.14
N/A
Revenue
$26,331,218.00
N/A
Revenue This Year
N/A
$24.54
Revenue Next Year
N/A
$33.15
P/E Ratio
$37.24
N/A
Revenue Growth
1.76
N/A
52 Week Low
$57.21
$8.12
52 Week High
$119.40
$15.41

Technical Indicators

Market Signals
Indicator
NVEC
DCTH
Relative Strength Index (RSI) 65.04 58.81
Support Level $63.38 $10.31
Resistance Level N/A $12.48
Average True Range (ATR) 7.92 0.58
MACD 0.80 0.09
Stochastic Oscillator 76.42 75.33

Price Performance

Historical Comparison
NVEC
DCTH

About NVEC NVE Corporation

NVE Corp develops and sells devices that use spintronics, a nanotechnology that relies on electron spin. It manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data. The company's products include Digital sensors, Medical sensors, Rotation Sensors, GT Sensors, Angle Sensors, Analog sensors, MSOP Isolators, Passive-In Transceivers, and others. The company manufactures high-performance spintronic products including sensors and couplers. The company's designs are based on giant magnetoresistance GMR and tunneling magnetoresistance TMR combined with integrated circuitry.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: